SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-044348
Filing Date
2022-02-16
Accepted
2022-02-16 16:01:44
Documents
8
Period of Report
2022-02-16

Document Format Files

Seq Description Document Type Size
1 6-K d315741d6k.htm 6-K 11773
2 EX-99.1 d315741dex991.htm EX-99.1 11040
3 GRAPHIC g315741ex99_1s1g1.jpg GRAPHIC 487186
4 GRAPHIC g315741ex99_1s2g1.jpg GRAPHIC 599684
5 GRAPHIC g315741ex99_1s3g1.jpg GRAPHIC 393551
6 GRAPHIC g315741ex99_1s4g1.jpg GRAPHIC 172362
7 GRAPHIC g315741ex99_1s5g1.jpg GRAPHIC 277756
8 GRAPHIC g315741ex99_1s6g1.jpg GRAPHIC 312870
  Complete submission text file 0001193125-22-044348.txt   3114599
Mailing Address SCIENCE & TECH PARK, EAST R&D BLDG, 3 FL EAST R&D BUILDING, 3RD FLOOR 6 BEIJING WEST ROAD, TAICANG F4 215400
Business Address SCIENCE & TECH PARK, EAST R&D BLDG, 3 FL EAST R&D BUILDING, 3RD FLOOR 6 BEIJING WEST ROAD, TAICANG F4 215400 86 512 5357 7866
Connect Biopharma Holdings Ltd (Filer) CIK: 0001835268 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40212 | Film No.: 22643506
SIC: 2834 Pharmaceutical Preparations